08:00 , Jan 19, 2004 |  BC Week In Review  |  Company News

Structural GenomiX, Eli Lilly deal

The companies expanded a 2003 deal under which Structural is using its high throughput structural determination technology to solve the crystal structures of LLY's targets (see BioCentury, April 21, 2003). As expanded, LLY will receive...
07:00 , Sep 29, 2003 |  BC Week In Review  |  Company News

Structural GenomiX, Boehringer Ingelheim deal

The companies expanded their January 2003 deal to allow Boehringer to use Structural's synchrotron beamline facility and high throughput structural determination technology to solve the crystal structures of additional Boehringer targets (see BioCentury, Jan. 20)....